Doctor Anywhere, a startup that takes an “omnichannel” approach to healthcare, today announced that it has raised SGD $ 88 million (approximately US $ 65.7 million) in Series C funding. The round has been completed by Asia Partners, with the participation of Novo Holdings, Philips and OSK-SBI Partners. It also included returning investors EDBI, Square Peg, IHH Healthcare, Kamet Capital and Pavilion Capital.
As part of the cycle, Asia Partners co-founder Oliver Rippel and Dr Amit Kakar, senior partner of Novo Holdings Equity Asia, will join the board of directors of Doctor Anywhere. The company’s Series C, which it says is one of the largest private fundraisers raised by a Southeast Asian health technology company, brings its total funding to more than $ 140 million. SGD dollars.
Doctor Anywhere’s omnichannel approach means that in addition to online consultations, it operates in-person clinics, offers home visits, drug deliveries, and operates an integrated marketplace for health and wellness products.
Founded in 2017 by Lim Wai Mun, Doctor Anywhere claims it now serves over 1.5 million users. It is available in Singapore, Malaysia, Thailand, Vietnam, and the Philippines, and at recently established tech hubs in Bangalore and Ho Chi Minh City.
Lim told TechCrunch in an email that when he started working on Doctor Anywhere, there were already successful telemedicine platforms in the US, UK and China, but the model was still there. emerging in Southeast Asia. A former investor, Lim started Doctor Anywhere as a side project because he had older parents who couldn’t leave their homes for medical visits.
Doctor Anywhere was launched as an online-only telehealth platform, but “we quickly realized that physical presence is very important in building trust with users,” Lim said. As a result, the company launched its home care services and physical clinics.
According to Doctor Anywhere estimates, the COVID-19 pandemic has accelerated the uptake of telehealth services in Southeast Asia by at least five years. The company has seen an increased demand for online medical consultations, drug deliveries and shopping in the market.
“Over the past year, we have more than doubled the size of our network from around 1,000 providers in early 2020 to currently nearly 2,500 healthcare professionals in Southeast Asia,” Lim said.
In response to the pandemic, Doctor Anywhere last year launched an online COVID-19 medical consultation clinic to provide on-demand consultations to people with suspicious symptoms. He also created an online mental wellness module with psychologists. Lim said the company has seen an increase in demand for mental health-related services, such as insomnia and anxiety.
Other telehealth startups in the region include WhiteCoat, Speedoc, and Doctor World. Lim said Doctor Anywhere wants to differentiate itself by quickly launching new products in response to user demands and “cultivating a balance between technology and human touch.”
The funding will be used to deepen Doctor Anywhere’s presence in its current markets and expand into new ones. It also plans to expand its technology infrastructure and big data capabilities for a better online and offline user experience, and will introduce new medical specialty modules, shorten drug administration times, and develop comprehensive care plans. personalized health.